VA Disability Rule Change Threatens Benefits for Millions of Veterans Despite Pause

The Veterans Affairs Department finds itself in hot water after attempting to implement a policy change that could have reduced disability benefits for millions of veterans, and rightfully so. Here are the facts.

On February 17, the VA directed its medical examiners to evaluate veterans’ disability levels based on how their conditions present while taking medication, rather than rating the underlying severity of the condition itself. This represents a fundamental shift in how the department assesses veteran disability claims.

The logic problem here is obvious. If a veteran’s PTSD symptoms are managed with medication, that does not mean the veteran is cured. It means the medication is working. Under this new guidance, a veteran whose debilitating condition is successfully controlled through treatment could see their disability rating reduced or eliminated entirely, despite the fact that without that treatment, they would be just as impaired as before.

Twenty-one Democrats and Independents on the House and Senate Veterans’ Affairs committees have now sent a letter to VA Secretary Doug Collins demanding permanent abandonment of this policy. They want confirmation by Monday that the rule is dead, a detailed timeline for its withdrawal, and a full explanation of why the department bypassed traditional rule-making procedures.

That last point matters significantly. The VA appears to have circumvented the standard regulatory process, which typically involves public comment periods and transparency. The letter accuses the department of using this rule as “a political maneuver aimed at cutting costs by abdicating VA’s obligation to service-disabled veterans.”

Secretary Collins announced on social media last week that the department would pause enforcement of the rule, writing that “while VA does not agree with the way this rule has been characterized, the department always takes veterans’ concerns seriously.” But here is the critical detail: the regulation remains on the books. A pause is not a withdrawal.

Veteran advocacy groups immediately denounced the guidance when it was announced, and their concerns are legitimate. The policy would create a perverse incentive structure where veterans might avoid treatment or medication that could improve their quality of life, fearing that successful symptom management would result in benefit reductions.

This is not complicated. We ask our veterans to serve, often at tremendous personal cost. When they return with service-connected disabilities, we have an obligation to provide the benefits and healthcare they have earned. Those benefits should not be contingent on whether a medication successfully masks their symptoms.

The VA’s apparent attempt to bypass normal rule-making procedures raises additional red flags. If this policy change is sound and justified, why not subject it to the standard process? Why not allow for public comment and proper vetting?

Republican leadership on the Veterans’ Affairs committees has remained notably silent on this issue, which is disappointing. This should not be a partisan matter. Veterans’ benefits transcend party lines, or at least they should.

The VA owes veterans and the American people a clear answer. Either permanently withdraw this rule or provide a compelling justification for why veterans whose conditions respond to treatment should face benefit reductions. A pause without explanation is insufficient.

Veterans kept their promises to America. America must keep its promises to veterans. This rule fails that basic test.

Related: Trump Declares Tariff Strategy Will Eliminate Income Tax Burden on Americans